The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan

By Koike T.   Ohara S.   Inomata Y.   Abe Y.   Iijima K.   Shimosegawa T.  

Inflammopharmacology, Vol. 15, Iss. 2, 2007-04 ,pp. : 61-64

Springer Publishing Company

Access to resources Recommend Favorite

Antiangiogenic Therapy for Metastatic Breast Cancer: Current Status and Future Directions

By Chan Arlene  

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 167-181

Adis International

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer: Current Status and Future Directions

By Bernard-Marty Chantal   Lebrun Fabienne   Awada Ahmad   Piccart Martine J.  

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1577-1591

Adis International

Access to resources Recommend Favorite

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

By Ajani Jaffer   Jiang Yixing   Faust Josephine   Chang Baochong   Ho Linus   Yao James   Rousey Steven   Dakhil Shaker   Cherny Richard   Craig Catherine   Bleyer Archie  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 353-357

Springer Publishing Company

Access to resources Recommend Favorite

Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise

By Zachos Ioannis   Konstantinopoulos Panagiotis A   Tzortzis Vassilios   Gravas Stavros   Karatzas Anastasios   Karamouzis Michalis V   Melekos Michael   Papavassiliou Athanasios G  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 7, 2010-07 ,pp. : 875-887

Informa Healthcare

Access to resources Recommend Favorite